GT
Healthcare & Life Sciences
Gemini Therapeutics
Gemini Therapeutics is a Healthcare & Life Sciences startup, most recent round Series C+, 1 tracked investor.
series-c-plus
series-c-plus
Stage
1
Investors
About Gemini Therapeutics
Gemini Therapeutics is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Gemini Therapeutics is a precision medicine company developing new therapies for dry age-related macular degeneration (dry AMD).
Explore Gemini Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.